AstraZeneca
AstraZeneca
Revolutionary RSV Treatment Approved in China!
BIOT
📝 AZ's Beyfortus authorized as first RSV treatment in China! 💊🇨🇳 Significant breakthrough in biotech industry. 👏😃
AstraZeneca’s Big Cell Therapy Breakthrough: Gracell Acquisition
BIOT
📢 AstraZeneca accelerates cell therapy ambitions through Gracell buy 🌱 Expanding capabilities, boosting oncology portfolio, and driving scientific innovation. 💪🏢🌍
AstraZeneca’s $12bn Chinese Biotech Power Move
BIOT
🌍💊 AstraZeneca boosts cell therapy projects by acquiring Gracell Biotechnologies for $1.2bn to fight cancer and autoimmune diseases. 🦠🚀 Expected to close Q1 2024.
